Exciting News from DM Clinical Research!
DM Clinical Research is proud to announce that we are a founding member of the newly launched Association of MultiSite Research Corporations (AMRC). This groundbreaking trade association unites 14 leading multisite organizations to tackle inefficiencies in clinical trials and create a more efficient, patient-focused research ecosystem.
At DM Clinical Research, we leverage 24+ sites across the U.S. to deliver high-quality, patient-centric studies across diverse therapeutic areas, including Infectious Disease, Cardio-metabolic, CNS, Immunology, and Vaccines. By integrating advanced technology and centralized management, we are at the forefront of driving innovation in clinical research.
?Why AMRC Is a Game-Changer:
- Addresses the reality that trial numbers grew by 19% from 2012 to 2022, while recruitment rates per site dropped 14% in oncology and 54% in non-oncology.
- Provides scalable solutions to meet the growing complexity of clinical trials
- Streamlines operations to combat inefficiencies, ensuring that life-saving treatments can be delivered faster and more reliably.
We are excited to collaborate with AMRC to advance the industry, champion innovation, and improve the clinical trial process for patients, sponsors, and investigators alike. Together, we’re shaping the future of medical research.
Learn more about AMRC and join their launch webinar on Thursday 30 January, where panelists will discuss the cost of inefficiencies in clinical trials to Sponsors and CROs and the critical role of multisite organizations in addressing these issues www.amrc.org/news.
#DMClinicalResearch #AMRC #ClinicalTrials #Innovation #TechnologyInResearch #DiversityInClinicalTrials #HealthcareLeadership #PatientCentricity
